Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells

OBJECTIVE: Chimeric antigen receptor (CAR) T cell therapy has recently emerged as a promising approach for the treatment of different types of cancer. Improving CAR T cell manufacturing in terms of costs and product quality is an important concern for expanding the accessibility of this therapy. One...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayadmanesh, Ali, Azadbakht, Mohammad, Yari, Kheirollah, Abedelahi, Ali, Shafaei, Hajar, Shanehbandi, Dariush, Baradaran, Behzad, Basiri, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591261/
https://www.ncbi.nlm.nih.gov/pubmed/37865876
http://dx.doi.org/10.22074/CELLJ.2023.2001712.1304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591261/
https://www.ncbi.nlm.nih.gov/pubmed/37865876
http://dx.doi.org/10.22074/CELLJ.2023.2001712.1304

Ejemplares similares